D. E. Shaw & Co., Inc. Eye Point Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $576,481 - $2.44 Million	100,960 New	100,960 $2.33 Million
Q4 2022 Feb 14, 2023	SELL	$2.37 - $7.2 $51,559 - $156,636	-21,755 Reduced 44.6%	27,025 $94,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $440,039 - $703,050	-63,224 Reduced 56.45%	48,780 $386,000
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $360,433 - $631,877	-49,715 Reduced 30.74%	112,004 $881,000
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $1.01 Million - $1.65 Million	-116,953 Reduced 41.97%	161,719 $1.97 Million

Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $2.14 Million - $3.88 Million	210,623 Added 309.52%	278,672 $3.41 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $102,999 - $160,739	13,715 Added 25.24%	68,049 $709,000
Q2 2021 Aug 16, 2021	BUY	$8.69 - $11.08 $472,162 - $602,020	54,334 New	54,334 $489,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.